Tag: clinical trials

Centralized Monitoring Signals: How to Target Site Visits and SDV

November 16, 2025November 15, 2025 digi

Centralized Monitoring Signals: How to Target Site Visits and SDV Centralized Monitoring Signals: How to Target Site Visits and SDV Effective monitoring in clinical trials is essential for ensuring compliance with Good Clinical Practice (GCP) and regulatory requirements. With the evolution of clinical research, centralized monitoring has emerged as a pivotal strategy for enhancing data…

Monitoring per GCP (On-site/Remote)

Applying 5 Whys and Fishbone Techniques to Protocol and GCP Deviations

November 16, 2025November 15, 2025 digi

Applying 5 Whys and Fishbone Techniques to Protocol and GCP Deviations In the realm of clinical trials, addressing deviations is critical for maintaining compliance with Good Clinical Practice (GCP) and ensuring the integrity of data. Root Cause Analysis (RCA) is an essential tool that assists clinical operations, regulatory affairs, and medical affairs professionals in identifying…

Root Cause Analysis (5 Whys, Fishbone)

Coordinating Vendors and Suppliers at Investigator Sites: A Practical Playbook

November 16, 2025November 15, 2025 digi

Coordinating Vendors and Suppliers at Investigator Sites: A Practical Playbook Coordinating Vendors and Suppliers at Investigator Sites: A Practical Playbook Introduction to Vendor and Supplier Coordination in Clinical Trials In the increasingly complex landscape of clinical trials, the coordination of vendors and suppliers at investigator sites has become paramount for the successful delivery of projects….

Vendor/Supplier Coordination at Sites

Lab, Imaging and Home Health Vendors: Who Does What at the Site Level

November 16, 2025November 15, 2025 digi

Lab, Imaging and Home Health Vendors: Who Does What at the Site Level Lab, Imaging and Home Health Vendors: Who Does What at the Site Level Clinical trials are instrumental in advancing medical knowledge and improving patient care. However, they cannot be conducted effectively without robust vendor and supplier coordination. This article provides a step-by-step…

Vendor/Supplier Coordination at Sites

GCP-Compliant Monitoring Strategies: Balancing On-Site and Remote Approaches

November 16, 2025November 15, 2025 digi

GCP-Compliant Monitoring Strategies: Balancing On-Site and Remote Approaches In clinical research, ensuring compliance with Good Clinical Practice (GCP) is paramount for the successful execution of clinical trials. It not only guarantees the safety of trial participants but also ensures the integrity and credibility of the data. This document serves as a comprehensive guide for clinical…

Monitoring per GCP (On-site/Remote)

Risk-Based Monitoring Under ICH E6(R3): From Theory to Execution

November 16, 2025November 15, 2025 digi

Risk-Based Monitoring Under ICH E6(R3): From Theory to Execution Risk-Based Monitoring Under ICH E6(R3): From Theory to Execution In the fast-evolving landscape of clinical trials, particularly within oncology clinical research, the emphasis on maintaining high-quality standards of data and patient safety is paramount. ICH E6(R3) introduces a shift toward Risk-Based Monitoring (RBM) principles that enhance…

Monitoring per GCP (On-site/Remote)

Root Cause Analysis in Clinical Trials: Going Beyond Surface Symptoms

November 16, 2025November 15, 2025 digi

Root Cause Analysis in Clinical Trials: Going Beyond Surface Symptoms Root Cause Analysis in Clinical Trials: Going Beyond Surface Symptoms Root cause analysis (RCA) is a critical process in maintaining the quality and integrity of clinical trials. By identifying the underlying causes of problems, clinical operations, regulatory affairs, and medical affairs professionals can address issues…

Root Cause Analysis (5 Whys, Fishbone)

Transitioning Participants to Standard of Care or New Studies

November 16, 2025November 15, 2025 digi

Transitioning Participants to Standard of Care or New Studies In the realm of clinical research, transitioning participants from clinical trials to standard of care or enrolling them in new studies is a critical process that demands meticulous planning and execution. This article aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a…

Close-Out Visits & Archiving

Decommissioning Study Systems and Vendor Contracts at Close-Out

November 16, 2025November 15, 2025 digi

Decommissioning Study Systems and Vendor Contracts at Close-Out Effective close-out procedures are a critical phase in the lifecycle of clinical trials. The process of decommissioning study systems and managing vendor contracts at close-out ensures compliance, safeguards data, and prepares the trial for regulatory inspection. This tutorial serves as a step-by-step guide for clinical operations, regulatory…

Close-Out Visits & Archiving

Integrating Source Data Requirements Into Protocol and SAP

November 16, 2025November 15, 2025 digi

Integrating Source Data Requirements Into Protocol and SAP Integrating Source Data Requirements Into Protocol and SAP In the realm of applied clinical trials, the integration of source data requirements into the study protocol and statistical analysis plan (SAP) constitutes a critical aspect of compliance with regulatory standards. As clinical trials evolve, regulatory bodies such as…

Source Data & ALCOA++